fadrozole has been researched along with Nausea in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, O; Abe, R; Asaishi, K; Enomoto, K; Kajiwara, T; Nomura, Y; Tominaga, T; Wada, T; Yoshida, M | 1 |
Abe, O; Abe, R; Aoyama, H; Asaishi, K; Enomoto, K; Kajiwara, T; Ohasi, Y; Tominaga, T; Yoshida, M | 1 |
Bonnefoi, HR; Coombes, RC; da Luz, RJ; Dowsett, M; Houston, SJ; Powles, TJ; Rubens, RD; Smith, IE; Trunet, PF | 1 |
Buzdar, A; Howell, A | 1 |
1 review(s) available for fadrozole and Nausea
Article | Year |
---|---|
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
3 trial(s) available for fadrozole and Nausea
Article | Year |
---|---|
[Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Estradiol; Fadrozole; Female; Humans; Middle Aged; Nausea; Postmenopause; Vomiting | 1994 |
[Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial].
Topics: Administration, Oral; Adult; Aged; Anorexia; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Postmenopause | 1994 |
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Confidence Intervals; Double-Blind Method; Fadrozole; Female; Flushing; Humans; Middle Aged; Nausea; Tamoxifen; Time Factors; Treatment Failure; Treatment Outcome | 1996 |